SELLAS Life Sciences Gr (SLS) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-0.07 and quarterly revenue of N/A.
In the most recent quarter (Q1), SELLAS Life Sciences Gr reported EPS of $-0.05, beating estimates of $-0.06 by 0.17%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
SELLAS Life Sciences Gr has beaten EPS estimates in 8 consecutive quarters.
Over the last 4 quarters, SELLAS Life Sciences Gr has averaged an EPS surprise of 0.18% and a revenue surprise of 0.00%.
Analyze the earnings history of SELLAS Life Sciences Gr using advanced sorting and filters.
The chart below shows SELLAS Life Sciences Gr's reported EPS compared to analyst estimates over recent quarters.
The chart below shows SELLAS Life Sciences Gr's reported revenue compared to analyst estimates over recent quarters.
SELLAS Life Sciences Gr (SLS) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
The Actual EPS was $-0.05, which beat the estimate of $-0.06.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-12 | $-0.05 | $-0.06 | 16.7 % |
| Q4 | 2026-03-19 | $-0.05 | $-0.06 | 16.7 % |
| Q3 | 2025-11-12 | $-0.06 | $-0.08 | 25.0 % |
| Q2 | 2025-08-12 | $-0.07 | $-0.08 | 12.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2023-11-09 | $0 | $8.67M | -100.0 % |
| Q2 | 2023-08-10 | $0 | $3.25M | -100.0 % |